jobs

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Healthy Returns: Novo Nordisk’s Wegovy deal with CVS won't derail Eli Lilly's obesity market dominance
Tags Biotech and Pharmaceuticals Novo Nordisk A/S Health care industry
From CNBC.com News
Novo Nordisk cuts 2025 guidance on weaker-than-expected Wegovy sales, posts first-quarter profit beat
Tags LILLY DRN Trade Abbvie Inc
From CNBC.com News
How much a $1,000 investment in Hims & Hers at its IPO would be worth now
Tags Novo Nordisk A/S Make It: Next Gen Investing Hims & Hers Health Inc
From CNBC.com News
Hims & Hers brings former Amazon executive into C-suite
Tags Health care industry Enterprise Novo Nordisk A/S
From CNBC.com News
Cramer's week ahead: Earnings from Disney, Palantir and Uber
Tags Palantir Technologies Inc Advanced Micro Devices Inc Business
From CNBC.com News
Inside the deal: Roche and Zealand Pharma's $5.3 billion obesity drug gambit
Tags Abbvie Inc Biotechnology LILLY DRN
From CNBC.com News
CVS to boost access to Novo Nordisk's weight loss treatment Wegovy for patients on its drug plans
Tags Business Biotechnology Health & Science
From CNBC.com News
Novo Nordisk opens weight loss drug Wegovy to Hims & Hers, Ro and Life MD telehealth
Tags Hims & Hers Health Inc Companies Health care industry
From CNBC.com News
Novo Nordisk scores major legal win that bars many compounded versions of Wegovy, Ozempic
Tags Breaking News: Business Business News Novo Nordisk A/S
From CNBC.com News
Healthy Returns: Trump seeks to change Medicare drug price negotiations in a win for pharma
Tags Bristol/Myers Squibb Co Health & Science Humana Inc
From CNBC.com News
5 European stocks to watch this earnings season as Trump's tariffs hit
Tickers OIL
Tags Trade Earnings Boeing Co
From CNBC.com News
Eli Lilly's weight loss pill succeeds in first late-stage trial on diabetes patients
Tags Biotechnology Business Health & Science
From CNBC.com News
CNBC Daily Open: Consumers are worried over the economy. The White House insists it’ll be fine
Tags Asia Markets Novo Nordisk A/S JPMorgan Chase & Co
From CNBC.com News
Pfizer scraps daily weight loss pill after liver injury in one patient
Tags Health & Science Business Biotechnology
From CNBC.com News
Autos, pharma, luxury and more: The global sectors soaring after Trump's tariffs walkback
Tags Economy Autos Breaking News: Economy
From CNBC.com News
Trump drops Biden's proposal for Medicare to cover obesity drugs like Wegovy and Zepbound
Tags Health care industry Companies Social issues
From CNBC.com News
The biggest winners and losers in Europe as Trump announces sweeping tariffs
Tags AstraZeneca PLC Kering SA Europe Economy
From CNBC.com News
Pharma tariff relief likely short-lived with sector-specific duties on the horizon
Tags Pharmaceuticals Biotech and Pharmaceuticals Novartis AG
From CNBC.com News
Novo Nordisk's diabetes pill slashes risk of cardiovascular complications by 14% after four years
Tags Health care industry Companies Pharmaceuticals
From CNBC.com News
Novo Nordisk defends disappointing next-gen obesity drug: 'It will be an important product'
Tags Biotechnology Pharmaceuticals LILLY DRN
From CNBC.com News
Novo Nordisk says copycat compounders are hurting Wegovy sales, may take legal action
Tags LILLY DRN Pharmaceuticals Biotech and Pharmaceuticals
From CNBC.com News
CNBC Daily Open: Consumers and CFOs alike are expecting a recession in the U.S.
Tags Tesla Inc Market Outlook Markets
From CNBC.com News
CNBC Daily Open: Fears of a U.S. recession intensify among consumers and CFOs
Tags Markets Market Outlook World Markets
From CNBC.com News
Healthy Returns: Novo Nordisk scoops up Chinese obesity drug to compete with Eli Lilly
Tags Health care industry Novo Nordisk A/S Biotech and Pharmaceuticals
From CNBC.com News
Software giant SAP becomes Europe's most valuable firm amid German stock market boom
Tags Novo Nordisk A/S Markets LVMH Moet Hennessy Louis Vuitton SE
From CNBC.com News
Eli Lilly will soon release key data on its weight loss pill. Here's why it could be a game-changer
Tags Structure Therapeutics Inc Novo Nordisk A/S Pharmaceuticals
From CNBC.com News
Novo Nordisk's next-gen obesity drug CagriSema had investors excited. Now they're not so sure
Tags Business News Novo Nordisk A/S Pharmaceuticals
From CNBC.com News
Zepbound copycats remain online despite FDA ban
Tags Business News Breaking News: Business Biotech and Pharmaceuticals
From CNBC.com News
Healthy Returns: Wegovy is linked to an increased risk of hair loss, study suggests
Tags Dexcom Inc Healthy Returns Biotech and Pharmaceuticals
From CNBC.com News
5 things to know before the stock market opens Monday
Tags 5 Things to Know Markets Politics
From CNBC.com News
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

More ways to get to us

Medicine Hat News Twitter Twitter
Medicine Hat News Facebook Facebook
Medicine Hat News Instagram Instagram
Medicine Hat News YouTube YouTube
Medicine Hat News Tumblr Tumblr

About Us

Contact the Medicine Hat News

922 Allowance Ave SE
Medicine Hat, AB T1A 3G7

Office hours: 8:30 a.m.-4:30 p.m. Monday to Friday, closed Saturday Sunday and statutory holidays.

[P] 403.527.1101
[F] 403-527-0737

Print Advertising: 403.528.5659
National Advertising: 403.528.5766
Online Advertising: 403.528.5698
Classifieds: 403.526.7653

© 1996-2024 The Medicine Hat News